Aurora Cannabis (TSX:ACB): Why You Should Buy the After-Earnings Dip

It is always a crucial time when one of the top cannabis companies releases its earnings report. Given the nascent nature of the industry, the performance of these firms gives us important clues as to how the market is evolving.

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is the latest top pot company to release its financial results.

Let’s see how Aurora performed.

Before a fall…

As the old proverb goes, pride comes before a fall. That is perhaps what happened to Aurora Cannabis during the last quarter.

Just about a month ago, the Edmonton-based marijuana company predicted it would post revenues in the neighborhood of $100 million to $107 million. The consensus analyst estimates also projected that Aurora’s revenues would break the $100 million mark, placing them at around $108 million for the quarter.

However, the company failed to deliver on its promise and failed to live up to analysts estimates. Aurora’s revenues “only” came in at $98.9 million. As a result, the firm’s share price dropped sharply during the after-hour trading session following its earnings release. 

Although holding Aurora accountable for its miss is important, it is equally essential to focus on the big picture. All things considered, the marijuana company’s revenues weren’t bad at all. After all, the $98.9 million figure represented a 415% increase year over year, and, more importantly, a 52% sequential increase.

Note that Aurora’s biggest rival in the Canadian market — Canopy Growth — failed to deliver a sequential revenue increase during its last quarter.

As the Canadian market tightens, it is becoming harder for cannabis firms to acquire and maintain a notable share of the market. Aurora, though, managed to deliver serious organic growth in this competitive environment. 

Further, the company’s medical segment seems to be firing on all cylinders. Aurora’s average net selling price for recreational product fell by about 6%, but its average retail price for medical products remained constant. There is bound to be a supply glut in the recreational market eventually, which will drag down prices and margins.

Fortunately, Canadian cannabis companies are anxiously awaiting the launch of the derivative market. Thus, although the lion’s share of Aurora’s revenues came from its recreational segment, that shouldn’t be cause for concern.

Finally, the company continues to increase its production capacity. During the quarter, Aurora added several new cultivation facilities, which led to an 86% sequential increase in production volume. 

The bottom line

Aurora has more tricks up its sleeve. The company recently made an acquisition that will improve its standing in the lucrative CBD market. All these developments should help the firm maintain strong top line growth.

Lastly, I still believe Aurora will eventually find a partner with deep pockets that will further improve its prospects. All these factors make Aurora one of the better plays in the cannabis market, in my opinion. 

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Prosper Junior Bakiny owns shares of Aurora Cannabis. 

Source: The Fool
Aurora Cannabis (TSX:ACB): Why You Should Buy the After-Earnings Dip
The Fool

The Motley Fool
Contributor at mjcanada.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News